BRL-26830A

CAT: 0804-HY-19002Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-19002Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BRL-26830A is a β-adrenergic receptor agonist. BRL-26830A reduces body weight and increases metabolic rate in obese mouse models. BRL-26830A stimulates insulin release and significantly reduces blood glucose levels in ICR mouse models. BRL-26830A can be used to study endocrine and metabolic diseases such as obesity and diabetes[1][2][2].
CAS Number
[87857-42-9]
UNSPSC
12352100
Target
Adrenergic Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Smiles
O=C(O)/C=C/C(O)=O.O=C(OC)C1=CC=C(C[C@@H](NC[C@@H](O)C2=CC=CC=C2)C)C=C1.[1/2]
Molecular Formula
C19H23NO3.1/2C4H4O4
Molecular Weight
371.45
References & Citations
[1]Connacher AA, et al. Clinical studies with the beta-adrenoceptor agonist BRL 26830A. Am J Clin Nutr. 1992 Jan;55 (1 Suppl) :258S-261S.|[2]Arch JR, et al. Thermogenic and antiobesity activity of a novel beta-adrenoceptor agonist (BRL 26830A) in mice and rats. Am J Clin Nutr. 1983 Oct;38 (4) :549-58. |[3]Yoshida T. The antidiabetic beta 3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin. Am J Clin Nutr. 1992 Jan;55 (1 Suppl) :237S-241S. d
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-12716BRL-44408
HY-106863BRL 35135
HY-19117BRL-32872
HY-117928BRL 55834
HY-19072BRL-36378
HY-118200BRL-41992
HY-106820BRL 34778
HY-13221-01BRL 54443
HY-19070BRL-52656
HY-121008Brl 20596

Alternative Products

CatalogName
ARI0018BRL
MBS3609896-01BRL 50481
004562BRL 44408
MBS5766228BRL-42715
sc-200154BRL-37344
sc-203855ABRL 54443
BUP06245-01BRL-50481
B2245-25BRL-54443
B2265-5BRL-15572
MF-0049996-01Brl 26314

Popular Products